Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Hoffmann

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2011
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, TanzaniaSteffen Geis, Leonard Maboko, Elmar Saathoff, et al.
Frontiers in Immunology|June 7, 2023
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patientsOliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, et al.
Genome Medicine|May 18, 2021
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerCorinna Keup, Vinay Suryaprakash, Siegfried Hauch, et al.
Journal of Virology|September 28, 2007
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infectionChristof Geldmacher, Clive Gray, Martha Nason, et al.
AIDS Research and Human Retroviruses|July 13, 2006
Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, TanzaniaKarl-Heinz Herbinger, Martina Gerhardt, Sucheep Piyasirisilp, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 5, 2012
FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial resultsChristian Buchbender, Sherko Kuemmel, Oliver Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2018
Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast CancerTilman D Rachner, Sabine Kasimir-Bauer, Andy Göbel, et al.
AIDS Research and Human Retroviruses|August 24, 2004
HIV type 1 subtypes among blood donors in the Mbeya region of southwest TanzaniaMiguel A Arroyo, Michael Hoelscher, Eric Sanders-Buell, et al.
Therapeutic Advances in Medical Oncology|May 20, 2020
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosisGalatea Kallergi, Oliver Hoffmann, Ann-Kathrin Bittner, et al.
Human Immunology|January 23, 2016
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsLisa König, Sabine Kasimir-Bauer, Oliver Hoffmann, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2011
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, TanzaniaSteffen Geis, Leonard Maboko, Elmar Saathoff, et al.
Frontiers in Immunology|June 7, 2023
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patientsOliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, et al.
Genome Medicine|May 18, 2021
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerCorinna Keup, Vinay Suryaprakash, Siegfried Hauch, et al.
Journal of Virology|September 28, 2007
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infectionChristof Geldmacher, Clive Gray, Martha Nason, et al.
AIDS Research and Human Retroviruses|July 13, 2006
Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, TanzaniaKarl-Heinz Herbinger, Martina Gerhardt, Sucheep Piyasirisilp, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 5, 2012
FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial resultsChristian Buchbender, Sherko Kuemmel, Oliver Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2018
Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast CancerTilman D Rachner, Sabine Kasimir-Bauer, Andy Göbel, et al.
AIDS Research and Human Retroviruses|August 24, 2004
HIV type 1 subtypes among blood donors in the Mbeya region of southwest TanzaniaMiguel A Arroyo, Michael Hoelscher, Eric Sanders-Buell, et al.
Therapeutic Advances in Medical Oncology|May 20, 2020
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosisGalatea Kallergi, Oliver Hoffmann, Ann-Kathrin Bittner, et al.
Human Immunology|January 23, 2016
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsLisa König, Sabine Kasimir-Bauer, Oliver Hoffmann, et al.
Pageof 12